JP2019174923A - Management method of medicament - Google Patents

Abstract

To provide a technique capable of applying stealth printing technique to medicament, for example, capable of managing the medicament in a tablet unit, by printing to a tablet and an aluminium foil on a rear face of a PTP sheet.SOLUTION: The invention is configured so that, pieces of visible information 11, 12, 13 being general management information, and invisible information 15 being additional information are printed in overprint, on both surfaces of a tablet 10 and on an aluminium foil on a rear face of a PTP sheet. The invisible information is for example, a two-dimensional dot code 15 which is printed in stealth printing, and can be read using a dedicated reading unit 33. By applying such a stealth printing technique to medicament, only general management information printed as visible information can be presented to a person who takes medicament, and more detail additional information encoded can be provided to a medical worker such as a pharmacist.SELECTED DRAWING: Figure 1

Description

  The present invention relates to a management method or management system for a pharmaceutical product (the drug itself or a direct container filled with the drug).

  In the quality control of pharmaceutical products by a pharmaceutical company, various information is printed on the packaging box, PTP sheet, etc. of the pharmaceutical products that have passed the final inspection as a product. Conventionally, as information printed on such a pharmaceutical package, for example, a logo of a pharmaceutical company, a drug name, a manufacturing date, a manufacturing number, etc., a medical worker (doctor, nurse, pharmacist) and patient are The printed information is used as primary information for identifying the drug.

  In addition, when dispensing at a pharmacy or hospital, a medical worker needs to identify what the drug is even after the drug is removed from the package. Therefore, for example, on the surface of each tablet, minimum information for medical personnel to identify the tablet, such as the drug name of the tablet and the content of the active ingredient, is printed. In recent years, two-color printing has been performed on the tablet surface for the purpose of further improving the identification of information. For example, if the amount of the active ingredient contained in one tablet is 20 mg, the color of the active ingredient of the tablet will be clarified by changing the printing color, such as blue if it is 40 mg, and green if it is 40 mg. Can be connected.

  Furthermore, as the printing technology based on the ink jet method has become higher in definition, it is now technically possible to print a barcode having a width of 0.1 mm or less on the surface of the tablet. For example, in order to manage medicines in units of tablets, it is considered effective to employ such code information having a large amount of information. However, management information by bar code is not necessarily necessary information for patients (medicine users), and many patients have psychological resistance to taking tablets with bar codes themselves.

  In view of such a background, the inventors pay attention to making at least a part of the management information printed on the medicine invisible (stealth) and apply this technology so that it becomes simpler and more beneficial than before. In addition, we have been proposing various management methods for pharmaceutical products and examining applications. As a known prior art relating to stealth printing, for example, Patent Document 1 discloses information using an invisible ink that is invisible under white light and emits fluorescence in the visible light range when exposed to ultraviolet light, and such invisible ink. There are disclosures about pharmaceuticals marked with.

Japanese translation of PCT publication No. 2007-510796

  An object of the present invention is to provide a new technique related to drug management, such as application of stealth printing technology to a drug, which enables simple and beneficial management of drug administration in units of tablets, for example. .

  The present invention is a pharmaceutical management method in which visible information and invisible information are printed, wherein the invisible information is read from the medicine using a reading unit, and the additional information of the medicine is read from the read invisible information. A method for managing medicines, wherein the medicines are managed using the obtained additional information.

  In this pharmaceutical management method, the invisible information is preferably two-dimensional code information. As the two-dimensional code information, for example, a QR code (registered trademark), a data matrix, a dot code, and the like are preferable.

  In addition, according to the management method of pharmaceutical products, invisible information including certificate information is printed on a pharmaceutical product certified as legitimate, and the pharmaceutical product is genuine based on the certificate information included in the read invisible information. It preferably includes making a determination.

  In addition, the method for managing medicines includes that the invisible information includes information on the manufacturing number of the medicine, and that the medicine is genuine based on the certificate information included in the read invisible information and the information on the manufacturing number associated therewith. It is preferable to include determining that it is.

  In addition, the method for managing medicines determines that the medicine is genuine under one condition that the invisible information is encrypted and printed on the medicine, and the read invisible information is decrypted. It is preferable to include.

  In addition, the method for managing a medicine preferably includes the additional information including information on at least a year and month when the medicine is manufactured, and managing an expiration date of the medicine based on the obtained additional information. .

  In addition, the drug management method includes information on the manufacture of a plurality of drugs registered in the drug registration data in the database, and the management server stores dispensing information including prescription information of the person (drug user) who prescribed the drug. It preferably includes receiving and additionally registering the dispensing information in the drug registration data associated with the drug specified from the received dispensing information.

  In the method for managing medicines, it is preferable that link information for accessing a user account for managing information on the user is added to the dispensing information additionally registered in the medicine registration data.

  In the method for managing medicines, link information for accessing medicine registration data corresponding to medicines prescribed for the user is preferably added to the user account.

  In addition, when the management server receives the invisible information from one terminal, the management method of the pharmaceutical supplies the information on the pharmaceutical specified from the invisible information to the user account associated with the terminal. It is preferable to include adding as a dosing history.

  Moreover, it is preferable that the management method of a pharmaceutical includes the said management server adding the said prescription information to the user account which manages the said user's information.

  Moreover, it is preferable that the management method of a pharmaceutical includes providing the said user with the guidance information based on the said prescription information.

  In addition, when the management server receives the invisible information from one terminal, the management method of the medicine obtains prescription information from the user account associated with the terminal, and the management server manages the medicine based on the received invisible information. It preferably includes identifying the medicinal product on which the invisible information is printed, and checking the consistency between the identified medicinal product and prescription information obtained from the user account.

  In addition, in the medicine management method, the administration server provides the user with medication guide information on the medicine to be taken at the time of taking when the prescription information obtained from the user account has come. It is preferable to include.

  According to the present invention, for example, general management information printed as visible information on a medicine can be presented to a patient taking the medicine, and in addition to general management information for a medical worker such as a pharmacist, the medicine Additional information printed as invisible information can also be provided. By applying technology to print such visible and invisible information on medicines, it is possible to provide, for example, the administration management of medicines in tablet units and the trace management of medicines after shipment in a simple and beneficial manner. become able to.

It is a figure which shows the outline | summary of the cloud management system of a pharmaceutical by one Embodiment of this invention. It is a figure which shows the control means for implement | achieving various management service functions in a cloud management system. It is a figure which shows the example of the general management information (visible information) printed on the one surface of the tablet. It is a figure which shows the example (dot code) of the additional information (invisible information) overprinted on the same surface of the tablet. It is a figure which shows the other example (data matrix) of the additional information (invisible information) overprinted on the same surface of the tablet. It is a schematic diagram of the printing apparatus which prints visible information and invisible information on a tablet. It is a figure for demonstrating the example which encodes additional information to a two-dimensional code (for example, dot code or a data matrix). It is a figure for demonstrating the example which encrypts additional information and encodes it to a two-dimensional code (for example, dot code or a data matrix). It is a figure which shows the structural example of pharmaceutical registration data. It is a figure for demonstrating the outline | summary of the reader for reading invisible information. It is a figure which shows the structural example of the pharmaceutical registration data to which dispensing information was added. It is a figure which shows the data structural example of a user account. It is a figure which shows the data structural example of the user account to which the dosing history was added.

FIG. 1 is a diagram showing an overview of a pharmaceutical cloud management system according to an embodiment of the present invention. FIG. 2 is a diagram showing control means for realizing various management service functions according to the present invention in the cloud management system 60.
In FIG. 1, between a pharmaceutical company, a pharmacy, a drug taker (patient), a system such as a hospital or a terminal device (including a portable terminal) and a cloud management system 60, an electronic device such as the Internet is used. Information signals are exchanged by the method. In addition, in the management server 61, the pharmacy system 30, the portable terminal 40 owned by the patient, etc., means or functions described below are realized by a computer provided in each of them performing arithmetic processing according to a predetermined program.
Moreover, this invention can also include the pharmaceutical of any aspect regardless of a tablet, a capsule, a powder etc. in the object of management. However, here, tablets are taken as an example of pharmaceuticals, and a plurality of embodiments including modifications will be described in detail.

<< Printing of management information by pharmaceutical companies and registration in the system >>
In pharmaceutical quality control by a pharmaceutical company, various management information is printed on a pharmaceutical product that has passed the final inspection. Here, FIG. 3A shows an example of general management information printed on one surface of the tablet 10. FIG. 3B shows an example of additional information that is stealth-printed on the surface of the same tablet 10. As illustrated in FIGS. 3A and 3B, visible management information and invisible additional information are printed on the tablet 10 of this embodiment.

  Here, “visible” in this specification means that it can be seen with the naked eye under visible light (for example, white light). “Invisible” means that it cannot be seen with the naked eye under visible light or cannot be easily seen. However, information that is normally invisible but is visualized through exposure by a method such as irradiation with ultraviolet light or a special filter is also included in the “invisible” information here. “Stealth printing” refers to printing invisible information using a stealth ink described later, or printing itself printed with stealth ink. Furthermore, since the stealth ink and the printing surface (for example, the surface of the tablet) have the same color (for example, white), the case where the printing cannot be read is also included as “invisible”.

  As the visible management information printed on the tablet 10, for example, as shown in FIG. 3A, a drug name 11, a content 12 of an active ingredient contained in the tablet, a shop name 13 of a pharmaceutical company, and the like are common. These are printed on both sides of the tablet 10 in alphabets or numbers. The visible information can be printed in color such that the content 12 is blue, for example, and the shop name 13 is green. For example, the printing color may be changed to blue if the amount of the active ingredient contained in one tablet is 20 mg, and green if it is 40 mg. Further, in addition to alphabets or numbers, non-readable code information such as barcodes may be printed.

  The general management information as described above is required in the market where pharmaceuticals are distributed. On the other hand, for medical professionals such as pharmacists, there are other drug information (also called “additional information”) that they want to know, and it is difficult to secure a printable space including them. There are challenges. Therefore, in the present embodiment, the effective display area of information in the tablet 10 is doubled by overprinting the invisible information on the visible information.

  For example, since the dot code 15 shown in FIG. 3B is invisible under white light, even if it is overprinted on the visible information (medicine name 11, content 12, shop name 13) in FIG. Will not be damaged. In addition, it becomes possible to provide additional information that the drug user does not want to use in a form limited to those who want to use it, such as medical workers.

  The above invisible information is preferably jetted and fixed on the surface of the tablet 10 using, for example, edible stealth ink. As the edible stealth ink, both pigment-based and dye-based inks can be used. For example, in the case of pigment-based stealth ink, invisible information (stealth print information) printed on the tablet 10 can be clearly photographed by exposing the surface of the tablet 10 with a dedicated device. Further, the dye-based stealth ink has a characteristic of fluorescence when irradiated with blue light. Therefore, it is possible to color stealth printing using a commercially available irradiating tool such as black light, whereby invisible information (stealth printing information) can be easily read.

  In the present embodiment, a two-dimensional code (for example, a dot code shown in FIG. 3B) is described as an example of invisible information, but the present invention is not limited to this. The dot code is read by bit-converting an arrangement pattern of dots existing in a 2 mm square frame by image processing, for example. As another example of the two-dimensional code, a data matrix (see FIG. 3C), a QR code (registered trademark) not shown, or the like can be used. In addition, for example, the manufacturing date and serial number or serial number or lot number of a pharmaceutical product may be stealth-printed with numbers or characters without being encoded.

  FIG. 4 is a schematic diagram of a printing apparatus 21 that prints visible information and invisible information on the tablet 10 by an inkjet method. In the printing apparatus 21, the printing unit includes two stages, a front surface printing unit 211A and a back surface printing unit 211B. The front surface printing unit 211A includes a transport unit 212A, a first color ink head 213A, a second color ink head 214A, a stealth ink head 215A, and a curing agent head 216A from the upstream to the downstream of the transport unit 212A. ing. The back side printing unit 211B has the same arrangement configuration as the above-described front side printing unit 211A, the transport unit 212B, the first color ink head 213B, the second color ink head 214B, the stealth ink head 215B, and the curing agent head 216B. It has.

  First, the tablet feeder 210 sequentially supplies a plurality of tablets 10 in a line to the transport unit 212A of the front surface printing unit 211A. When the row of tablets 10 is conveyed under the first color ink head 213A, the drug name 11 and the shop name 13 are printed on each tablet 10 in black, for example. Next, when the tablets 10 are conveyed under the second color ink head 214A, the active ingredient content 12 is printed on each tablet 10 in, for example, blue. Subsequently, for example, the dot code 15 is stealth-printed on each tablet 10 conveyed to the stealth ink head 215A. In this way, the invisible information (15) is overprinted on the visible information (11, 12, 13). Thereafter, a curing agent is sprayed onto the surface of each tablet 10 by the curing agent head 216A, and the ink is overcoated.

  The tablets 10 thus subjected to the printing process by the front surface printing unit 211A are inverted at the lower part of the transport unit 212A so that the back surface is up, and are similarly supplied to the back surface printing unit 211B in the next stage. Further, the visible information (11, 12) is also passed through the first color ink head 213B, the second color ink head 214B, the stealth ink head 215B, and the curing agent head 216B on the back surface of the tablet 10 in the same manner as the front surface. 13), the invisible information (15) is overprinted.

  In order to fix the ink to the tablet 10, the curing units 217A and 217B cure the curing agent by irradiating each surface with ultraviolet rays as the tablet 10 is dried.

  Additional information printed on the tablet 10 as invisible information includes, for example, the date of manufacture of the tablet 10, a manufacturing number, an address code (URL: Uniform Resource Locator) for accessing a dedicated site, information on a genuine product certificate, etc. It is.

  The expiration date of the tablet 10 can be managed based on at least the date of manufacture read from the invisible information.

  The address code is information for the computer of the management server 61 and the pharmacy system 30 to access a dedicated site such as the drug information database 70 operated by a general incorporated foundation, an academic society, the private sector, or the like. For example, by accessing a URL read from the tablet 10, a medical worker can obtain the latest drug information such as the usage, dose, medicinal effect, and handling precautions of the tablet 10.

  The genuine product certificate is information that the pharmaceutical company proves that the tablet 10 is a genuine product. The form of the genuine certificate may be any of digital data to be printed, a two-dimensional code, or an image (stamp). Stealth printing of a genuine product certificate makes it easy to determine the authenticity while making forgery of pharmaceuticals difficult. Furthermore, the safety and reliability of the certificate can be further improved by associating the genuine product certificate with the production number.

One or more combinations of these additional information can be stealth printed on the tablet 10. Further, all or part of the additional information may be two-dimensionally encoded.
For example, as shown in FIG. 5A, the encoding means 22 can encode the set of the manufacture date and the manufacture number of the medicine (tablet 10) into, for example, two-dimensional dot arrangement information 15 forming a dot code. Further, as shown in FIG. 5B, the encoding means 22 may encrypt the digital data of the additional information using the secret encryption key 23 and encode it into the two-dimensional dot arrangement information 15.

  Code information encrypted using the encryption key 23 can be decrypted (decrypted) only by a decryption key paired with the encryption key 23. Using this property, it is possible to apply the encrypted two-dimensional code to authentic certification or authenticity determination of pharmaceutical products. That is, for example, it is possible to determine that the medicine is a genuine product on the condition that the dot code 15 can be decrypted with a public decryption key. On the other hand, if the dot code 15 cannot be decoded, it can be determined that the drug is not a genuine product.

  In the cloud management system 60, the drug registration means 611 of the management server 61 receives management information such as the manufacturing date and the manufacturing number, which is information related to the manufacturing of the drug transmitted from the pharmaceutical company (first information registrant). , It is registered in the managed medicine database 62. FIG. 6 shows a configuration example of the drug registration data 621 registered in the managed drug database 62. In this way, information related to the manufacture of a plurality of different types of pharmaceutical products is registered in the corresponding pharmaceutical registration data 621 of the managed pharmaceutical database 62 for each pharmaceutical product number, for example, preferably for each single tablet.

<< Registration of dispensing information by pharmacies and use of system >>
A patient who is taking medication at home medical care, etc., submits a prescription given by the doctor to the insurance pharmacy when purchasing the drug. In a pharmacy, a pharmacist first checks the contents of a prescription and then dispenses a medicine.

  Prior to dispensing, the pharmacist checks the patient for other medications in addition to the treatments listed in the prescription. If you are taking other medicines, make sure that you take them together. In addition, the pharmacist can investigate whether the patient has had allergies or side effects in the past with respect to the prescribed medicine, and can suggest a change to a substitute medicine in some cases in cooperation with a doctor. Whether or not other medicines are being taken and whether or not allergies are present can be checked from interviews with patients, a description in a medicine notebook, a record in the electronic drug history system 31 of a pharmacy, and the like. Further, when the patient has a later-described doser account 631 in the cloud management system 60, the dose history information is obtained from the individual dose history data 632 by the dose history information providing unit 616 of the management server 61. can do.

  When the pharmacist decides the medicine to be dispensed, the pharmacist takes out the medicine from the stock in the pharmacy and checks whether it is a genuine product or whether the expiration date has passed. In the present embodiment, the reading device 33 reads stealth printing information (invisible, for example, dot code 15) printed on the medicine on the medicine package or individual tablet 10, and the decoding means 32 decodes the dot code 15. Thus, additional information such as the date of manufacture of the drug can be acquired. Also, authenticity determination can be performed based on the genuine product certificate included in the dot code 15.

  Further, the pharmacy system 30 may transmit the genuine product certificate read from the stealth print information of the medicine to the cloud management system 60 together with the manufacturing number. The drug registration data 621 of the managed drug database 62 is associated with a genuine product certificate and a production number, and the genuine product matching means 614 of the management server 61 collates these pieces of information to verify the authenticity of the drug. The determination can be performed accurately with higher reliability.

  Furthermore, the pharmacy system 30 can obtain more detailed information about the medicine by sending stealth print information (for example, dot code 15) read from the medicine to the cloud management system 60 and inquiring it. For example, the drug information search means 6131 searches the latest information such as the usage, dose, efficacy, and handling precautions of the drug by accessing the URL of the drug information database 70 included in the dot code 15. Can do. Then, the medicine information output unit 6133 can return the acquired latest information to the pharmacy system 30.

  In addition, when a patient brings a remaining medicine or an unknown medicine, the system can be used to instantly check what the medicine is or whether it has expired. That is, in the same manner as described above, the invisible dot code 15 printed on the medicine is read by the reading device 33, and the decoding means 32 decodes the dot code 15, whereby the medicine can be identified instantaneously. . In addition to specifying the medicine, the date of manufacture can be determined based on the dot code 15, and authenticity can be determined. Furthermore, the pharmacy system 30 can also obtain more detailed information regarding the medicine by making an inquiry to the cloud management system 60 based on the read dot code 15 as described above.

  In addition, according to the present system, stealth printing information can be effectively used even during the dispensing inspection of pharmaceutical products. In particular, in the present embodiment, since the dot code 15 is stealth-printed on each tablet, for example, as shown in FIG. Individual additional information can be electronically read at once from the plurality of types of tablets 10a, 10b, 10c. This makes it possible to partially automate the inspection of the dispensing and to improve the efficiency of insurance pharmacy operations.

When the inspection of the dispensing medicine is completed, the pharmacy system 30 transmits the dispensing information of the medicine to the management server 61 of the cloud management system 60.
Dispensing information includes the name of the pharmacy responsible for dispensing, the date of dispensing, the name of the pharmacist (dispenser, examiner), etc., as well as the patient name, prescribing physician name, medical institution name, Contains prescribing information such as the quantity of medicines and usage.
The patient name, doctor name, medical institution name, pharmacist name, and the like may include ID information that can identify them. When the patient has a user account 631 to be described later, the account name or account ID may be transmitted.

The dispensing information registration means 612 of the management server 61 receives the dispensing information (including prescription information) transmitted from the pharmacy (second information registrant) and registers the medicine associated with the medicine specified from the dispensing information. In the data 621, the transmitted dispensing information is additionally registered.
Here, FIG. 8 shows a configuration example of the pharmaceutical registration data 621 to which dispensing information is added. The dispensation information transmitted from the pharmacy includes information for identifying the medicinal product (for example, a combination of medicinal product name and manufacturing number encoded in the dot code 15). Dispensing information is added to the end of the drug registration data 621 retrieved from the information.

  In addition, the dispensing information registration unit 612 searches the user database 63 and finds the user account 631 from the patient name or the like, and the link information (specifically, for accessing the user account 631). (Jump destination address) is added to the data portion of the dispensing information of the specified drug registration data 621.

  Note that FIG. 8 shows an example in which the dispensing information of one user is added, but when the drug is dispensed (prescription) to multiple users, the dispensing information for each user is the drug. Recorded in the registration data 621.

<< Registration of medication information and use of system by drug users >>
Returning to FIG. 2, the dose management application providing means 615 provided in the management server 61 provides various applications by the system through a terminal 40 such as a personal computer or a mobile phone to a patient receiving home medical care, for example. It is.

  Among them, the account management means 6151 is a means for managing a user account 631 for managing information of a person who has been prescribed a medicine. More specifically, the account management means 6151 creates a taker account 631 in the taker database 63, registers taker information, registers the use terminal 40, changes these registration contents, and the like.

  For example, a drug user (the third information registrant; the patient himself or his caregiver, etc.) installs a dose management application 41 on the terminal 40, and the name, date of birth, e-mail address ( By inputting necessary information such as contact information, it is possible to easily create a user account 631 for the user. FIG. 9 shows a data configuration example of the user account 631.

When the account management means 6151 searches the managed medicine database 62 and finds the medicine registration data 621 to which the user account 631 is linked, the link information (specific information) of the medicine registration data 621 is stored in the user account 631. Specifically, a jump address for accessing the drug registration data 621 is added.
Further, it is preferable that the account management means 6151 cites at least prescription information (prescription medicine and its usage) of the user himself / herself described in the medicine registration data 621 and adds it to the user account 631.

  FIG. 9 shows an example in which one kind of medicine is prescribed for the user. If a plurality of medicines are prescribed for the user, prescription information for each medicine is recorded in the user account 631. Is done.

  The dosing guide 6153 can provide prescription information (such as when, what, and how many tablets to be taken) referred to from the dosing user account 631 to the dosing person through the dosing management application 41. In addition, the medication guidance means 6153 can also provide prescription information in a form that is easy to visually discriminate by displaying photographs such as the appearance and packaging of tablets using the display function of the medication management application 41.

  Also, immediately before taking the tablet 10, the user sends invisible information (for example, dot code 15) stealth-printed on the tablet 10 to the management server 61, which is used as the history data 632 of the user. Can be registered. The stealth print information printed on the tablet 10 or the like can be read by the reading means 42 that is an image sensor incorporated in the terminal 40, for example. Alternatively, the stealth print information may be taken into the dose management application 41 using an external dedicated reader.

  FIG. 10 shows an example of the user account 631 to which the dose history data 632 has been added by the dose history management means 6152 of the management server 61. When the management server 61 receives stealth print information from a certain terminal 40, the management server 61 first specifies a drug (for example, tablet 10) based on the stealth print information (specifically, specifies drug registration data 621 of the drug). . Each time the administration history management unit 6152 receives the stealth print information, the administration history management unit 6152 sequentially adds the administration history data 632 of the tablet 10 specified from the stealth print information to the user account 631 associated with the terminal 40. To go.

  In addition, the medication history management means 6152 checks whether the medicine specified from the stealth print information received from a certain terminal 40 is consistent with the prescription information recorded in the user account 631 associated with this terminal 40. Can do. For example, if the tablet 10 that the patient intends to take is different from the prescription information or does not match the prescribed usage (dosing time, dose, etc.), the dosing guide 6153 takes the dosing of the terminal 40. A warning can be immediately sent to the user through the management application 41. Thereby, it can lead to prevention of the mistaking of a medicine.

  If the stealth print information is not transmitted from the terminal registered for use in the user account 631 even though the prescription information recorded in the user account 631 is reached, The guide means 6153 can also send a guide mail that prompts the user to take the medicine. Thereby, it can lead to prevention of forgetting to take medicine.

  In addition, the medication history management means 6152 determines whether the medication at hand of the patient is based on the difference between the initial prescription amount of the medication indicated by the prescription information in the user account 631 and the previous dose indicated by the medication history data 632. It is possible to calculate the remaining amount and the number of days until the medicine runs out. Then, when the remaining number of days until there are no more drugs is, for example, three days or less, the dosing guide 6153 can also send a guide mail prompting the user to prescribe the dosing. Thereby, it can lead to the avoidance of the situation where a patient runs out of a medicine, for example by home medical care.

  In some cases, a user who has been prescribed a medicine wants to know easily what the remaining medicine is at hand or if the expiration date has passed. According to the present system, the stealth print information is read from the terminal 40 such as a smartphone owned by itself and transmitted to the management server 61, so that the medicine can be easily inquired. The drug inquiry means 6154 searches the registered drug database 62 for drug registration data 621 associated with stealth print information. As described above, the drug registration data 621 records the manufacturing date and dispensing date (open date of the package, etc.) of the drug, and the drug inquiry means 6154 stores the drug information recorded in the drug registration data 621. And information such as the dosage deadline can be promptly returned to the terminal 40 of the inquirer.

10 Tablets (Pharmaceuticals) 11 Drug name 12 Content 13 Pharmaceutical company name 15 Two-dimensional code (invisible information, additional information)
DESCRIPTION OF SYMBOLS 21 Printing apparatus 22 Encoding means 30 Pharmacy system 31 Electronic drug history system 32 Decoding means 33 Reading apparatus (reading means)
40 terminal 41 dose management application 60 cloud management system 61 management server 62 managed drug database 63 doser database 611 drug registration means 612 dispensing information registration means 613 drug information provision means 615 dose management application provision means 621 drug registration data 631 doser account 632 Medication history data 6131 Drug information search means 6133 Drug information output means 6151 Account management means 6152 Medication history management means 6153 Medication guide means 6154 Drug inquiry means

Claims (14)

A method for managing pharmaceuticals with visible and invisible information printed thereon,
Reading the invisible information from the drug using reading means, and obtaining additional information of the drug from the read invisible information,
A method for managing a medicine, wherein the medicine is managed using the obtained additional information.   The pharmaceutical management method according to claim 1, wherein the invisible information is two-dimensional code information. Invisible information, including certificate information, is printed on authorized drugs.
The method for managing a medicine according to claim 1 or 2, comprising determining that the medicine is a genuine product based on the certificate information included in the read invisible information. The invisible information includes information on the serial number of the drug,
The method for managing a medicine according to claim 3, comprising determining that the medicine is a genuine product based on the certificate information included in the read invisible information and the manufacturing number information associated therewith. The invisible information is encrypted and printed on the medicine;
The management method according to any one of claims 1 to 4, further comprising determining that the drug is a genuine product on the condition that the read invisible information is decoded. The additional information includes information on at least the year and month when the medicinal product was manufactured;
The management method of the pharmaceutical according to any one of claims 1 to 5, comprising managing the expiration date of the pharmaceutical based on the obtained additional information. Information on the manufacture of multiple drugs is registered in the drug registration data in the database.
Management server
Receiving dispensing information including prescription information of a person who has been prescribed a medicine (taker), and additionally registering the dispensing information in the medicine registration data associated with the medicine identified from the received dispensing information. The management method of the pharmaceutical of Claim 1 or 2 containing.   The pharmaceutical management method according to claim 7, wherein link information for accessing a user account for managing information on the user is added to the dispensing information additionally registered in the drug registration data.   The pharmaceutical management method according to claim 8, wherein link information for accessing drug registration data corresponding to a drug prescribed to the user is added to the user account. When the management server receives invisible information from one terminal,
The medicine management method according to claim 7, comprising adding information on a medicine specified from the invisible information as a medicine history of the medicine to a user account associated with the terminal. The management server is
The pharmaceutical management method according to claim 7, comprising adding the prescription information to a user account for managing the information of the user.   The pharmaceutical management method according to claim 11, comprising: providing the user with medication guide information based on the prescription information. When the management server receives invisible information from one terminal,
Obtaining prescription information from a user account associated with the device;
The method according to claim 11, further comprising: identifying a medicine on which the invisible information is printed based on the received invisible information; and checking consistency between the identified medicine and prescription information obtained from the user account. 12. A method for managing a pharmaceutical product according to 12. The management server is
The medicine management according to claim 11, comprising providing, to the user, medication guide information of a medicine to be taken at the time of taking when the time of taking indicated by the prescription information obtained from the user account is reached. Method.

Images